世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4605 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腫瘍血液検査の市場動向 ・企業の競争状況、市場シェア ・腫瘍血液検査の種類別市場規模と予測2016-2027（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その） ・腫瘍血液検査の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター） ・腫瘍血液検査の北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍血液検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍血液検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍血液検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍血液検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Guardant Health、Trovagene、Genomic Health、Roche、Bio-Techne、Pathway Genomics） ・結論

Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool.

Market Analysis and Insights: Global Oncology Blood Testing Market
The global Oncology Blood Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Blood Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Blood Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Blood Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Blood Testing market.

Global Oncology Blood Testing Scope and Market Size
Oncology Blood Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Blood Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Protein Testing
Tumor Marker Testing
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Blood Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Protein Testing
1.2.3 Tumor Marker Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Blood Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oncology Blood Testing Market Perspective (2016-2027)
2.2 Oncology Blood Testing Growth Trends by Regions
2.2.1 Oncology Blood Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Blood Testing Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Blood Testing Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Blood Testing Industry Dynamic
2.3.1 Oncology Blood Testing Market Trends
2.3.2 Oncology Blood Testing Market Drivers
2.3.3 Oncology Blood Testing Market Challenges
2.3.4 Oncology Blood Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oncology Blood Testing Players by Revenue
3.1.1 Global Top Oncology Blood Testing Players by Revenue (2016-2021)
3.1.2 Global Oncology Blood Testing Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Blood Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Blood Testing Revenue
3.4 Global Oncology Blood Testing Market Concentration Ratio
3.4.1 Global Oncology Blood Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Blood Testing Revenue in 2020
3.5 Oncology Blood Testing Key Players Head office and Area Served
3.6 Key Players Oncology Blood Testing Product Solution and Service
3.7 Date of Enter into Oncology Blood Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Blood Testing Breakdown Data by Type
4.1 Global Oncology Blood Testing Historic Market Size by Type (2016-2021)
4.2 Global Oncology Blood Testing Forecasted Market Size by Type (2022-2027)

5 Oncology Blood Testing Breakdown Data by Application
5.1 Global Oncology Blood Testing Historic Market Size by Application (2016-2021)
5.2 Global Oncology Blood Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oncology Blood Testing Market Size (2016-2027)
6.2 North America Oncology Blood Testing Market Size by Type
6.2.1 North America Oncology Blood Testing Market Size by Type (2016-2021)
6.2.2 North America Oncology Blood Testing Market Size by Type (2022-2027)
6.2.3 North America Oncology Blood Testing Market Size by Type (2016-2027)
6.3 North America Oncology Blood Testing Market Size by Application
6.3.1 North America Oncology Blood Testing Market Size by Application (2016-2021)
6.3.2 North America Oncology Blood Testing Market Size by Application (2022-2027)
6.3.3 North America Oncology Blood Testing Market Size by Application (2016-2027)
6.4 North America Oncology Blood Testing Market Size by Country
6.4.1 North America Oncology Blood Testing Market Size by Country (2016-2021)
6.4.2 North America Oncology Blood Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oncology Blood Testing Market Size (2016-2027)
7.2 Europe Oncology Blood Testing Market Size by Type
7.2.1 Europe Oncology Blood Testing Market Size by Type (2016-2021)
7.2.2 Europe Oncology Blood Testing Market Size by Type (2022-2027)
7.2.3 Europe Oncology Blood Testing Market Size by Type (2016-2027)
7.3 Europe Oncology Blood Testing Market Size by Application
7.3.1 Europe Oncology Blood Testing Market Size by Application (2016-2021)
7.3.2 Europe Oncology Blood Testing Market Size by Application (2022-2027)
7.3.3 Europe Oncology Blood Testing Market Size by Application (2016-2027)
7.4 Europe Oncology Blood Testing Market Size by Country
7.4.1 Europe Oncology Blood Testing Market Size by Country (2016-2021)
7.4.2 Europe Oncology Blood Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oncology Blood Testing Market Size (2016-2027)
8.2 Asia-Pacific Oncology Blood Testing Market Size by Type
8.2.1 Asia-Pacific Oncology Blood Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Blood Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Blood Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Blood Testing Market Size by Application
8.3.1 Asia-Pacific Oncology Blood Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Blood Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Blood Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Blood Testing Market Size by Region
8.4.1 Asia-Pacific Oncology Blood Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Blood Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oncology Blood Testing Market Size (2016-2027)
9.2 Latin America Oncology Blood Testing Market Size by Type
9.2.1 Latin America Oncology Blood Testing Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Blood Testing Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Blood Testing Market Size by Type (2016-2027)
9.3 Latin America Oncology Blood Testing Market Size by Application
9.3.1 Latin America Oncology Blood Testing Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Blood Testing Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Blood Testing Market Size by Application (2016-2027)
9.4 Latin America Oncology Blood Testing Market Size by Country
9.4.1 Latin America Oncology Blood Testing Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Blood Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oncology Blood Testing Market Size (2016-2027)
10.2 Middle East & Africa Oncology Blood Testing Market Size by Type
10.2.1 Middle East & Africa Oncology Blood Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Blood Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Blood Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Blood Testing Market Size by Application
10.3.1 Middle East & Africa Oncology Blood Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Blood Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Blood Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Blood Testing Market Size by Country
10.4.1 Middle East & Africa Oncology Blood Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Blood Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Guardant Health
11.1.1 Guardant Health Company Details
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Oncology Blood Testing Introduction
11.1.4 Guardant Health Revenue in Oncology Blood Testing Business (2016-2021)
11.1.5 Guardant Health Recent Development
11.2 Trovagene
11.2.1 Trovagene Company Details
11.2.2 Trovagene Business Overview
11.2.3 Trovagene Oncology Blood Testing Introduction
11.2.4 Trovagene Revenue in Oncology Blood Testing Business (2016-2021)
11.2.5 Trovagene Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Oncology Blood Testing Introduction
11.3.4 Genomic Health Revenue in Oncology Blood Testing Business (2016-2021)
11.3.5 Genomic Health Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Oncology Blood Testing Introduction
11.4.4 Roche Revenue in Oncology Blood Testing Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Details
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne Oncology Blood Testing Introduction
11.5.4 Bio-Techne Revenue in Oncology Blood Testing Business (2016-2021)
11.5.5 Bio-Techne Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Details
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Oncology Blood Testing Introduction
11.6.4 Pathway Genomics Revenue in Oncology Blood Testing Business (2016-2021)
11.6.5 Pathway Genomics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oncology Blood Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Protein Testing
Table 3. Key Players of Tumor Marker Testing
Table 4. Key Players of Others
Table 5. Global Oncology Blood Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oncology Blood Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oncology Blood Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Oncology Blood Testing Market Share by Regions (2016-2021)
Table 9. Global Oncology Blood Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Oncology Blood Testing Market Share by Regions (2022-2027)
Table 11. Oncology Blood Testing Market Trends
Table 12. Oncology Blood Testing Market Drivers
Table 13. Oncology Blood Testing Market Challenges
Table 14. Oncology Blood Testing Market Restraints
Table 15. Global Oncology Blood Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Oncology Blood Testing Market Share by Players (2016-2021)
Table 17. Global Top Oncology Blood Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Blood Testing as of 2020)
Table 18. Ranking of Global Top Oncology Blood Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Oncology Blood Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oncology Blood Testing Product Solution and Service
Table 22. Date of Enter into Oncology Blood Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Blood Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Oncology Blood Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Oncology Blood Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Oncology Blood Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Oncology Blood Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Oncology Blood Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Oncology Blood Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Oncology Blood Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Oncology Blood Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Oncology Blood Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Oncology Blood Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Oncology Blood Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Oncology Blood Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Oncology Blood Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Oncology Blood Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Oncology Blood Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Oncology Blood Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Oncology Blood Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Oncology Blood Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Oncology Blood Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Oncology Blood Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Oncology Blood Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oncology Blood Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oncology Blood Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oncology Blood Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Oncology Blood Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Oncology Blood Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Oncology Blood Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Oncology Blood Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Oncology Blood Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Oncology Blood Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Oncology Blood Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Oncology Blood Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Oncology Blood Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oncology Blood Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oncology Blood Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oncology Blood Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Oncology Blood Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Guardant Health Company Details
Table 63. Guardant Health Business Overview
Table 64. Guardant Health Oncology Blood Testing Product
Table 65. Guardant Health Revenue in Oncology Blood Testing Business (2016-2021) & (US$ Million)
Table 66. Guardant Health Recent Development
Table 67. Trovagene Company Details
Table 68. Trovagene Business Overview
Table 69. Trovagene Oncology Blood Testing Product
Table 70. Trovagene Revenue in Oncology Blood Testing Business (2016-2021) & (US$ Million)
Table 71. Trovagene Recent Development
Table 72. Genomic Health Company Details
Table 73. Genomic Health Business Overview
Table 74. Genomic Health Oncology Blood Testing Product
Table 75. Genomic Health Revenue in Oncology Blood Testing Business (2016-2021) & (US$ Million)
Table 76. Genomic Health Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Oncology Blood Testing Product
Table 80. Roche Revenue in Oncology Blood Testing Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Bio-Techne Company Details
Table 83. Bio-Techne Business Overview
Table 84. Bio-Techne Oncology Blood Testing Product
Table 85. Bio-Techne Revenue in Oncology Blood Testing Business (2016-2021) & (US$ Million)
Table 86. Bio-Techne Recent Development
Table 87. Pathway Genomics Company Details
Table 88. Pathway Genomics Business Overview
Table 89. Pathway Genomics Oncology Blood Testing Product
Table 90. Pathway Genomics Revenue in Oncology Blood Testing Business (2016-2021) & (US$ Million)
Table 91. Pathway Genomics Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Blood Testing Market Share by Type: 2020 VS 2027
Figure 2. Blood Protein Testing Features
Figure 3. Tumor Marker Testing Features
Figure 4. Others Features
Figure 5. Global Oncology Blood Testing Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Oncology Blood Testing Report Years Considered
Figure 10. Global Oncology Blood Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Oncology Blood Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Oncology Blood Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Oncology Blood Testing Market Share by Regions (2022-2027)
Figure 14. Global Oncology Blood Testing Market Share by Players in 2020
Figure 15. Global Top Oncology Blood Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Blood Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Oncology Blood Testing Revenue in 2020
Figure 17. Global Oncology Blood Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Oncology Blood Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Oncology Blood Testing Market Share by Type (2016-2027)
Figure 21. North America Oncology Blood Testing Market Share by Application (2016-2027)
Figure 22. North America Oncology Blood Testing Market Share by Country (2016-2027)
Figure 23. United States Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oncology Blood Testing Market Share by Type (2016-2027)
Figure 27. Europe Oncology Blood Testing Market Share by Application (2016-2027)
Figure 28. Europe Oncology Blood Testing Market Share by Country (2016-2027)
Figure 29. Germany Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oncology Blood Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Oncology Blood Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Oncology Blood Testing Market Share by Region (2016-2027)
Figure 39. China Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oncology Blood Testing Market Share by Type (2016-2027)
Figure 47. Latin America Oncology Blood Testing Market Share by Application (2016-2027)
Figure 48. Latin America Oncology Blood Testing Market Share by Country (2016-2027)
Figure 49. Mexico Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oncology Blood Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Oncology Blood Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Oncology Blood Testing Market Share by Country (2016-2027)
Figure 55. Turkey Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Oncology Blood Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Guardant Health Revenue Growth Rate in Oncology Blood Testing Business (2016-2021)
Figure 59. Trovagene Revenue Growth Rate in Oncology Blood Testing Business (2016-2021)
Figure 60. Genomic Health Revenue Growth Rate in Oncology Blood Testing Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Oncology Blood Testing Business (2016-2021)
Figure 62. Bio-Techne Revenue Growth Rate in Oncology Blood Testing Business (2016-2021)
Figure 63. Pathway Genomics Revenue Growth Rate in Oncology Blood Testing Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---